How to achieve and enhance professionalism in rheumatology
Professional attitudes, virtues, and behavior are key to providing the best standards of care. There are many challenges to the traditional values and...
Systematic reviews and meta-analysis in rheumatology: a gentle introduction for clinicians
Clinicians in rheumatology increasingly rely on systematic reviews to aid in evidence-based decision-making. Given time constraints, staying up-to-dat...
Evidence-based rheumatology practice
Evidence-based rheumatology is an ongoing effort, with continuing revision and update of recommendations. The initiatives on practice-based research t...
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training
The European League Against Rheumatism established a task force to develop points to consider for the assessment of competencies during rheumatology s...
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial
Inclusion body myositis is most frequent in patients older than 50 years. In this pilot study, we aimed to test the efficacy of sirolimus in patients...
German Mobile Apps in Rheumatology: Review and Analysis Using the Mobile Application Rating Scale (MARS)
The German App Store and Google Play store were systematically searched to identify German rheumatology mobile apps for patient and physician use. The...
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Data were collected from 47 rheumatology, dermatology, neurology, and pediatric clinics worldwide. A probability cut-off of 55%, corresponding to a sc...
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Flares of worsen...